Antibody responses against wild-type yellow fever virus and the 17D vaccine strain: Characterization with human monoclonal antibody fragments and neutralization escape variants

Virology

Volumn 337, Issue 2, 2005, Pages 262-272

  Daffis, Stephane ^a   Kontermann, Roland E ^a,c   Korimbocus, Jehanara ^b   Zeller, Hervé ^b   Klenk, Hans Dieter ^a   Ter Meulen, Jan ^a,d  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b National Reference Center for Arboviruses   (France)

^c UNIVERSITY OF STUTTGART   (Germany)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Antibody response; Envelope protein; Immune library; Monoclonal antibody fragments; Neutralizing epitope; Phage display; Yellow fever virus

Indexed keywords

AMINO ACID; DIMER; EPITOPE; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; VIRUS GLYCOPROTEIN; VIRUS VACCINE;

AFRICA; ANTIBODY RESPONSE; ARTICLE; CONFORMATION; CONTROLLED STUDY; GENOTYPE; HUMAN; MOLECULAR CLONING; MOUSE; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RISK ASSESSMENT; SERUM; YELLOW FEVER FLAVIVIRUS;

AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; ANTIBODY FORMATION; GENE PRODUCTS, ENV; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; PEPTIDE FRAGMENTS; PROTEIN CONFORMATION; VARIATION (GENETICS); VIRAL MATRIX PROTEINS; YELLOW FEVER VACCINE; YELLOW FEVER VIRUS;

YELLOW FEVER VIRUS;

EID: 20444414884     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2005.04.031     Document Type: Article

References (34)

1. A.D.T. Barrett, and E.A. Gould Comparison of neurovirulence of different strains of yellow fever virus in mice J. Gen. Virol. 67 1986 631 637
2. M.W. Brandriss, J.J. Schlesinger, E.E. Walsh, and M. Briselli Lethal 17D yellow fever encephalitis in mice: I. Passive protection by monoclonal antibodies to the envelope proteins of 17D yellow fever and dengue 2 viruses J. Gen. Virol. 67 1986 229 234
3. W.D. Crill, and G.J. Chang Localization and characterization of flavi-virus envelope glycoprotein cross-reactive epitopes J. Virol. 78 24 2004 13975 13986
4. R. Davies, and E.A. Padlan Antibody-antigen complexes Annu. Rev. Biochem. 59 1990 439 473
5. L.M. Dunster, H. Wang, K.D. Ryman, B.R. Miller, S.J. Watowich, P.D. Minor, and A.D. Barrett Molecular and biological changes associated with HeLa cell attenuation of wild-type yellow fever virus Virology 261 1999 309 318
6. H.R. Gelderblom, C. Kocks, J. L'Age-Stehr, and H. Reupke Comparative immunoelectron microscopy with monoclonal antibodies on yellow fever virus-infected cells: pre-embedding labelling versus immunocryo-ultramicrotomy J. Virol. Methods 10 1985 225 239
7. A.P. Goncalvez, R.H. Purcell, and C.-J. Lai Epitope determinants of a chimpanzee Fab antibody that efficiently cross-neutralizes dengue type 1 and type 2 viruses map to inside and in close proximity to the fusion loop of the dengue type 2 virus envelope glycoprotein J. Virol. 78 2004 12919 12928
8. E.A. Gould, A. Buckley, A.D.T. Barrett, and N. Cammack Neutralizing (54K) and nonneutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice J. Gen. Virol. 67 1986 591 595
9. A.D. Jennings, J.E. Whitby, P.D. Minor, and A.D. Barrett Comparison of the nucleotide and deduced amino acid sequences of the structural protein genes of the yellow fever 17DD vaccine strain from Senegal with those of other yellow fever vaccine viruses Vaccine 11 1993 679 681
10. A.D. Jennings, C.A. Gibson, B.R. Miller, J.H. Mathews, C.J. Mitchell, J.T. Roehrig, D.J. Wood, F. Taffs, B.K. Sil, and S.N. Whitby Analysis of a yellow fever virus isolated from a fatal case of vaccine-associated human encephalitis J. Infect. Dis. 169 1994 512 518
11. S. Kitchener Viscerotropic and neurotropic disease following vaccination with the 17D yellow fever vaccine, ARILVAX Vaccine 22 2004 2103 2105
12. R.E. Kontermann R.E. Kontermann S. Dübel Antibody Engineering 2001 Springer Heidelberg 137 148
13. R.E. Kontermann, P. Martineau, C.E. Cummings, A. Karpas, D. Allen, E. Derbbyshire, and G. Winter Enzyme immunoassays using bispecific diabodies Immunotechnology 3 1997 137 144
14. T. Korn, D.M. Nettelbeck, T. Volkel, R. Muller, and R.E. Kontermann Recombinant bispecific antibodies for the targeting of adenoviruses to CEA-expressing tumour cells: a comparative analysis of bacterially expressed single-chain diabody and tandem scFv J. Gene Med. 6 2004 642 651
15. R.J. Kuhn, W. Zhang, M.G. Rossmann, S.V. Pletnev, J. Corver, E. Lenches, C.T. Jones, S. Mukhopadhyay, P.R. Chipman, E.G. Strauss, T.S. Baker, and J.H. Strauss Structure of dengue virus: implications for flavivirus organization, maturation, and fusion Cell 108 2002 717 725
16. G.L. Lawrence, M.A. Burgess, and R.B. Kass Age-related risk of adverse events following yellow fever vaccination in Australia Commun. Dis. Intell. 28 2004 244 248
17. B.D. Lindenbach, and C.M. Rice Flaviviridae: the viruses and their replication D.M. Knipe P.M. Howley Fields Virology vol. I 2001 Lippincott, Williams and Wilkins Philadelphia 991 1041
18. M. Lobigs, L. Dalgarno, J.J. Schlesiger, and R.C. Weir Location of a neutralization determinant in the E protein of yellow fever virus (17D vaccine strain Virology 161 1987 474 478
19. J.D. Marks, H.R. Hoogenboom, T.P. Bonnert, J. McCafferty, A.D. Griffiths, and G. Winter By-passing immunization. Human antibodies from V-gene libraries displayed on phage J. Mol. Biol. 222 1991 581 597
20. M. Martin, T.F. Tsai, B. Cropp, G.J. Chang, D.A. Holmes, J. Tseng, W. Shieh, S.R. Zaki, I. Al-Sanouri, A.F. Cutrona, G. Ray, L.H. Weld, and M.S. Cetron Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases Lancet 358 2001 98 104
21. M.A. McArthur, M.T. Suderman, J.P. Mutebi, S.Y. Xiao, and A.D. Barrett Molecular characterization of a hamster viscerotropic strain of yellow fever virus J. Virol. 77 2003 1462 1468
22. T.P. Monath Yellow fever vaccine S.A. Plotkin W.A. Orenstein Vaccines 2004 Saunders Philadelphia, USA 1095 1176
23. T.P. Monath, and A.D.T. Barrett Pathogenesis and pathophysiology of yellow fever Adv. Virus Res. 60 2003 343 395
24. J.P. Mutebi, H.A. Wang, L. Li, and A.D. Bryant Phylogenetic and evolutionary relationships among yellow fever virus isolates in Africa J. Virol. 75 2001 6999 7008
25. S. Pincus, P.W. Mason, E. Konishi, B.A. Fonseca, R.E. Shope, C.M. Rice, and E. Paoletti Recombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever virus encephalitis Virology 187 1992 290 297
26. P.R. Post, R. Carvalho, and R. Galler Glycosylation and secretion of yellow fever virus nonstructural protein NS1 Virus Res. 18 1991 291 302
27. K.V. Pugachev, S.W. Ocran, F. Guirakhoo, D. Furby, and T.P. Monath Heterogeneous nature of the genome of the ARILVAX yellow fever 17D vaccine revealed by consensus sequencing Vaccine 20 2002 996 999
28. F.A. Rey, F.X. Heinz, C. Mandl, C. Kunz, and S.C. Harrison The envelope glycoprotein from the tick-borne encephalitis virus at 2 Å resolution Nature 375 1995 291 298
29. S.E. Robertson, B.P. Hull, O. Tomori, O. Bele, J.W. LeDuc, and K. Esteves Yellow fever: a decade of re-emergence J. Am. Med. Assoc. 276 1996 1157 1162
30. J.T. Roehrig Antigenic structure of flavivirus proteins Adv. Virus Res. 59 2003 141 175
31. K.D. Ryman, T.N. Ledger, R.C. Weir, J.J. Schlesinger, and A.D.T. Barett Yellow fever virus envelope protein has two discrete type-specific neutralizing epitopes J. Gen. Virol. 78 1997 1352 1356
32. K.D. Ryman, H. Xie, T.N. Ledger, G.A. Campbell, and A.D.T. Barrett Antigenic variants of yellow fever virus with an altered neurovirulence phenotype in mice Virology 230 1997 376 380
33. K.D. Ryman, T.N. Ledger, G.A. Campbell, S.J. Watowich, and A.D.T. Barrett Mutations in a 17D-204 vaccine substrain-specific envelope protein epitope alter the pathogenesis of yellow fever virus in mice Virology 244 1998 59 65
34. J. ter Meulen, M. Sakho, K. Koulemou, N. Magassouba, A. Bah, W. Preiser, S. Daffis, C. Klewitz, H.G. Bae, M. Niedrig, H. Zeller, M. Heinzel-Gutenbrunner, L. Koivogui, and A. Kaufmann Activation of the cytokine network is related to unfavourable outcome in Yellow fever J. Infect. Dis. 190 2004 1821 1827